Analyst Research

Report Title Price
Provider: Wright Reports
Provider: Reuters Investment Profile
Provider: Sadif Analytics Prime
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Panion & BF Biotech Inc announces new drug approval for Nephoxil in Japan

Friday, 17 Jan 2014 03:35am EST 

Panion & BF Biotech Inc:Says its authorized partner, Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd., received marketing approval for Nephoxil (named Riona in Japan), which is a kidney drug and developed by Panion & BF Biotech, in Japan on Jan. 17.Says the company to receive milestone money from Japan Tobacco and Torii Pharmaceutical. 

Company Quote

3.1 +1.12%
31 Oct 2014